Systematic review of the relation between smokeless tobacco and non-neoplastic oral diseases in Europe and the United States
2008

Smokeless Tobacco and Oral Health Issues

Sample size: 50 publication 10 minutes Evidence: moderate

Author Information

Author(s): Gerd Kallischnigg, Rolf Weitkunat, Peter N. Lee

Primary Institution: Philip Morris Products S.A.

Hypothesis

How does smokeless tobacco contribute to non-neoplastic oral diseases?

Conclusion

The review confirms a strong association between current smokeless tobacco use, especially snuff, and the prevalence of oral mucosal lesions, while the evidence for other oral health issues is less clear.

Supporting Evidence

  • 33 epidemiological studies show a strong dose-related effect of snuff on oral mucosal lesions.
  • Users in Scandinavia have nearly 100% prevalence of characteristic lesions.
  • Evidence suggests that quitting smokeless tobacco can lead to rapid regression of lesions.

Takeaway

Using smokeless tobacco can cause serious mouth problems, especially if you use snuff, but it's not clear how it affects other dental issues.

Methodology

The review analyzed 50 studies from Europe and the USA, focusing on the relationship between smokeless tobacco use and various oral diseases.

Potential Biases

Potential bias due to the authors' affiliations with tobacco companies and the selection of studies that may not represent the general population.

Limitations

Many studies had small sample sizes, inconsistent definitions of outcomes, and did not adequately control for confounding variables.

Participant Demographics

The studies included a mix of adults and adolescents, primarily from Scandinavia and the USA.

Statistical Information

P-Value

p<0.01

Confidence Interval

95% CI 0.5–6.7

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6831-8-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication